Inventurus Knowledge Solutions Limited (IKS), a prominent healthcare solutions provider, has secured approval from the Securities and Exchange Board of India (SEBI) to proceed with its initial public offering (IPO). This offering will allow the company to expand its influence in the U.S., Canada, and Australia, with a particular focus on the U.S. market, where its care enablement platform already supports numerous physician enterprises.

The IPO will consist of an offer for sale of up to 28.18 million equity shares, each with a face value of Rs1. Notable selling shareholders include members of the promoter group, such as the Ashra Family Trust, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, and Nishtha Jhunjhunwala Discretionary Trust. Additionally, individual stakeholders like Joseph Benardello, Gautam Char, Parminder Bolina, Jeffrey Philip Freimark, Berjis Minoo Desai, and Scott D Hayworth are also participating in the offer for sale.

IKS offers a comprehensive healthcare platform, providing both outpatient (ambulatory) and inpatient care services. Outpatient services include medical consultations, diagnosis, rehabilitation, and various treatments that do not require hospital admission. Inpatient care, by contrast, supports patients who require extended hospital stays.

The Book Running Lead Managers for this IPO include ICICI Securities, Jefferies India, JM Financial, J.P. Morgan India, and Nomura Financial Advisory and Securities (India), ensuring robust guidance and execution for the offering.